The Friday Show Presented By Monmouth Park: Talking Thoroughbred Makeover

Just as there are “baby” races at the track, off-track Thoroughbreds have their own kind of competition restricted to newcomers — the Thoroughbred Makeover, scheduled for Oct. 12-17 at the Kentucky Horse Park near Lexington, Ky.

The event, offering $100,000 in prize money and consisting of 10 different disciplines, brings together Thoroughbreds that are in their first year transitioning from the racetrack to a second career.

Jonathan Horowitz, who calls the races at Colorado's Arapahoe Park, has been the announcer at the Thoroughbred Makeover since 2015. Since January 2020, he's been documenting  his new avocation in a series of articles at the Paulick Report, “Horowitz On OTTBs,” highlighting the challenges and triumphs that come with working with off-track Thoroughbreds.

“I appreciate that it's not easy to do,” said Horowitz, who joins publisher Ray Paulick and editor in chief Natalie Voss on this week's Friday Show. “I appreciate that when you get it, it's one of the most rewarding feelings. It's a sport where … imagine if you're a basketball player and the basketball had a mind of its own.”

While Horowitz will not be competing at this year's Thoroughbred Makeover, Voss will be in the dressage ring at the Horse Park with her off-track Thoroughbred, Underscore (fondly known as Blueberry around the barn). She's a tireless advocate for giving ex-racehorses the best chance possible for a second career that can be just as rewarding for the horse as a trip to the winner's circle.

Watch this week's Friday Show, presented by Monmouth Park, below:

The post The Friday Show Presented By Monmouth Park: Talking Thoroughbred Makeover appeared first on Horse Racing News | Paulick Report.

Source of original post

Buying From The Back Ring: High-Stakes Snap Judgments At Thoroughbred Auctions

A Book 1 purchase at the Keeneland September Yearling Sale can entail months of careful shopping, from farm visits ahead of the auction to countless inspections, phone calls, and veterinary visits when the horses are on the sales grounds. When Book 5 comes around, and buyers are laying eyes on prospects for the first time in the back walking ring, that process is condensed down to about 20 minutes.

With so many horses going through the ring, and limited time and travel budgets to roam the barns inspecting horses at each consignment, many horsemen in the later books of the marathon sale will elect to find a spot in the back walking ring and inspect the horses as they come through, often standing shoulder-to-shoulder with several others doing the same thing. If they find one that meets their criteria, they'll follow the horse up to the ring to place a bid. Then, once the paperwork is complete, they'll often go back to the same spot and start the process over again.

It's a pressure cooker for buyers and sellers alike, as they weave between nervous horses and each other in a crowded, enclosed area, trying to get the best sightline for a yearling on the walk or hunting down the consignor to glance at the vet report.

The horses purchased in these books are crucial to filling the ranks for pinhookers and trainers around the country, and while the prices might not turn heads the way a seven-figure star might earlier in the sale, the buyers still shoulder a significant risk relative to their initial capital. To succeed in the long-term, their quick-twitch judgement with back ring horses has to be right more often than not.

So, what do keen judges lean on during the bloodstock realm's version of speed dating? For most, it comes down to the walk, the mind, and the budget.

“You can pick apart the book by pedigree at this point as much as you want, but honestly, we just look at individuals, and if we see something that catches our eye, we kind of go from there,” said Delaware Park-based trainer Chelsey Moysey. “You see the horse, see the page, and go on to vet reports and all of that. At this stage in the game, it moves fast, and that's what works for us.

“The biggest thing for me is the walk,” Moysey continued. “I want a good walker, a good shoulder, and a good hip. I can work with anything from the knees down, give or take, but I want to see a horse with a good shoulder and a good hip.”

In addition to how the young horses move, buyers often judged prospects on how they handled their surroundings. A yearling that could handle the sensory overload of the auction process was more likely to warrant a longer look than one hanging on to its composure by a thread.

“They've got to be smart-looking to me,” said Eric Foster, a trainer based in Kentucky and Indiana. “I haven't had a lot of luck with horses that weren't smart. I want to hang around with smart people and smart horses. And never back in the knee. A lot of my rules I make, I wind up having to break them a little bit, so it's hard for me to say, 'I'll never do this,' because then I'll be right there doing it.”

Foster said he comes to the sale with a number in his head in terms of setting a budget, but he allows some wiggle room if he feels he'd be getting adequate value at a higher price.

Moysey also said the horse will dictate the price in her eyes, but her goal was to come back with as many prospects within her overall budget as she could.

“We're still on the lower end of racing, so for us to spend $50,000 on an individual is a lot, but for us to spend $50,000 on two is great,” she said We try to look between the $20,000 to $30,000 range, and if we get something cheaper, great. That isn't happening right now, but we're trying.”

The intent of the buyer can also swing the type of horse they're looking for in the back ring. As buyers looking to race, Foster and Moysey said they were able to forgive certain conditions found on a vet report. Pinhook buyers, on the other hand, will need their horses to stand up to veterinary scrutiny when they're offered again in the spring, and it's hard to have a clean vet report as a 2-year-old if they didn't start with one as a yearling.

Crystal Ryan of South Carolina-based pinhook operation Mason Springs said she prefers to do her homework back at the barns, but the volume of horses in the catalog sometimes makes back ring buying a necessity. When it does, due diligence has to be done quickly, and juggling prospects can be a challenge.

“It all happens so fast, and it's so easy to lose track of one, when you get on one and you have to check on all those things,” she said. “It can be really hard, because one you like might not pass the vet, and then you look and the next horse you like is already going to the ring, and there's not enough time to call it in to the vet.”

[Story Continues Below]

Whereas Moysey was willing to forgive anything below the legs on a horse, Ryan's checklist was the exact opposite.

“First off, I try to look from the legs up, because if I look from the side, I will tend to like something that I probably shouldn't, so I really try to watch that walk, and see how correct they are,” she said. “Of course, there's no perfect horse, so they'll have a little deviation and you have to be a little forgiving.”

Buying to pinhook also means Ryan was not necessarily shopping for the horses she'd like, but the ones she expects potential buyers will like during the 2-year-old sales, both from a physical and pedigree standpoint. She admitted this has taken some fine-tuning of her critical eye.

“It does knock a lot of horses out that I would otherwise really like,” Ryan said. “I have an affinity for a turf horse and that doesn't really fit the bill, so I have to be really careful about that.”

What a back ring buyer does when they fall on a potential purchase can differ wildly, as well. Querying the consignor for the vet report is standard procedure, but how much conversation they have with the agent about the horse and the economics around it depends on the buyer.

“I really kind of keep myself to myself and just do my own thing,” said Midwest trainer John Ennis. “I just paddle my own canoe, really.

“It's a big investment that you're buying, so you want to make sure you're buying something with no soundness issues,” he continued. “Starting out on the right foot is the main thing.”

Book 5 of this year's Keeneland September sale has been unusually robust, and that has given the traditional back ring buyers more competition than they might have expected. Because buyers in the higher books have gotten pushed down into the later sessions, prices have been driven up, and buyers on a tighter budget have had to be even more shrewd than before about picking their spots.

Just because it's later in the sale and the average price has gone down, that doesn't mean it's gotten any easier to buy a horse than it was on the auction's opening day.

“It's hard to have a stone plan for it,” Foster said. “You need to be a little bit lucky.”

The post Buying From The Back Ring: High-Stakes Snap Judgments At Thoroughbred Auctions appeared first on Horse Racing News | Paulick Report.

Source of original post

$145,000 Tapiture Colt Tops Next-To-Last Day Of Keeneland September Yearling Sale

Two yearlings consigned by Paramount Sales, agent, led results of Thursday's penultimate session of the Keeneland September Yearling Sale in Lexington, Ky., when John Greathouse, agent for Glencrest Farm, paid $145,000 for a colt by Tapiture and Maddie Mattmiller, agent/Black Type Thoroughbreds purchased a filly from the first crop of Grade 1 winner Bolt d'Oro for $120,000.

Paramount Sales was the session's leading consignor with sales of $1,169,000 for 24 horses.

Keeneland sold 303 yearlings during Thursday's 10th session for $9,194,000, for an average of $30,343 and a median of $23,000. The cumulative gross for 2,428 yearlings sold through the ring is $348,885,500, for an average of $143,693 and a median of $75,000.

The session-topping Tapiture colt, a half-brother to stakes winners Watch This Cat and Stylish Citizen, is out of the winning Dayjur mare Informative Style. He is from the family of Grade/Group 1 winner Con Te Partiro.

The filly by Bolt d'Oro sold to Mattmiller, agent/Black Type Thoroughbreds is out of Julie's Jewelry, a stakes-placed daughter of Distorted Humor. She is from the family of Grade 1 winners General Challenge, Notable Career, Evening Jewel and Denman's Call.

Two yearlings sold for $100,000 each.

Raroma Stables purchased a colt by Silent Name (JPN) out of stakes winner Involuntary, by City Zip, for the amount. Hidden Brook, agent, consigned the colt, who is from the family of Group 2 winner Sir Gerry.

A colt by Commissioner out of stakes winner Rudy's Edge, by Added Edge, sold for $100,000 to Grade One Investments. Consigned by Wynnstay Sales, agent, he is from the family of stakes winners Sober Appeal and Plum Sober.

The session's leading buyer was Lothenbach Stables, which acquired four yearlings for $230,000.

The final session of the September Sale begins Friday at 10 a.m.

The auction is streamed live at Keeneland.com.

The post $145,000 Tapiture Colt Tops Next-To-Last Day Of Keeneland September Yearling Sale appeared first on Horse Racing News | Paulick Report.

Source of original post

At Long Last, We Know (Kind Of) What Was In Those Products Sold By The Indicted Pharmacist

For years, testing experts and regulators had looked at websites like RacehorseMeds and HorsePreRace and wondered about some of their most dramatically named products. Blood Building Explosion; White Lightning; Ice Explosion; Purple Pain – items with marketing as bright and attention-catching as the vibrant colors of the liquid inside the bottles had been a source of fascination for some time. Products that promised to “light one up” and that they “will not test” had no ingredients list, let alone a breakdown showing strengths of their active ingredients.

In her time at the Racing Medication and Testing Consortium, Dr. Mary Scollay said she had acquired bottles of these and other products from the two sites that later became part of the focus of FBI investigators. Rigorous testing had yielded mostly inactive ingredients, sugars, or harmless amino acids. Still, she had always wondered whether the makers of the substances were including some new, sinister form of performance enhancer that simply evaded even top-shelf testing.

Now, we know more about the instructions given to staff mixing up products at the direction of former pharmacist Scott Mangini, who had business involvement with both websites at various times. (Mangini was one of more than two dozen people indicted in March 2020 on drug adulteration and misbranding charges stemming from an alleged series of illegal doping rings in Thoroughbred and Standardbred racing.)

One of the final items filed by prosecutors just before Mangini's sentencing on Sept. 10 included a cache of documents seized in FBI searches related to the investigation of RacehorseMeds and HorsePreRace. Included in the public filing was a series of formulas for some of the products sold by RacehorseMeds, as well as a series of invoices for orders of product ingredients sent from a supplier based in Wuhan, China. (There was also a set of billing records for RacehorseMeds, but that was filed under seal so is inaccessible to media or the public.)

We asked Scollay and former HFL Sport Science laboratory director Dr. Rick Sams to take a look at those records and help us understand what they mean about the products sold on these sites.

Harmless, or not?

Many of the substances listed on these (and other, similar websites) were clearly intended to appear as cheaper, knock-off versions of prescription drugs already in FDA-approved mass manufacture. Usually, those shared the same names as the prescription products (clenbuterol, omeprazole, flunixin, etc.) but were offered to lay people with no requirement they be licensed veterinarians. Those substances had their own problems, but it was at least clear what was supposed to be in them.

The mysterious substances with proprietary names had been more intriguing for regulators. Formulas revealed that many of them contained nothing different from more innocuously-named oral supplements – vitamins like pyridoxine (B6) and thiamine (B1), minerals like iron and copper salts, and amino acids like L-tryptophan. Many of these things can be found naturally in feed or hay, and Scollay says there's no evidence that feeding extra of many of those ingredients produces any appreciable effect in a horse's health, let alone performance. A product named  Horse Power turns out to contain ATP, vitamins, amino acids, and di-isopropylamine dihydrochloride. It's true that they would not test, but it wouldn't be because they were magically hidden by masking agents; rather, they aren't usually tested for post-race because those substances are probably present in most horses being fed balanced diets.

Under the cloak of “proprietary formulas,” the websites managed to charge much more for those pedestrian ingredients than what they would have cost horsemen who knew what they were buying. Red Explosion Blood Builder, for example, is still listed for sale online for $35 for a 10-milliliter bottle, but according to its formulation it only contained .002 grams of B12, water, and a couple of stabilizers. The B12, according to shipping records, was purchased for $8 per gram. A mark-up is just good business of course, but injectable B12 is available from legitimate, FDA-approved mass manufacturers for less than $6 for a 100-milliliter bottle.

Besides being expensive, some of the products may not have actually been capable of being absorbed by horses' bodies, according to the formulas in the court filing. A product called TQ Explosion contained calcium levulinate, thiamine, tryptophan, and GABA.

“Calcium levulinate is a source of calcium,” said Sams. “Thiamine is a vitamin. Tryptophan is an essential amino acid. GABA is gamma aminobutyric acid and is prohibited. This product is made up in sterile water for injection instead of 0.9% sodium chloride so it may not be isotonic.”

The inclusion of salts is usually made in injectable formulas to ensure the solution is appropriately passed through the bloodstream. Blood cells are isotonic, meaning they naturally contain some salts. Pure water is naturally drawn in by salty solution, so exposure to pure water could make red blood cells swell and burst – that's why most IVs are run with saline and not sterile water. Leaving out any kind of salt probably didn't make the product risky to the horse, according to Sams, but it does mean it probably didn't get delivered throughout the body in any sort of useful way.

Sometimes, the proprietary formulas left our expert sources scratching their heads as to what the makers thought they were accomplishing. The frighteningly-named Allergy Explosion turns out to contain only formic acid.

“Formic acid is the substance that causes the stinging sensation in ant bites,” said Sams. “I don't think that injecting it in a horse is inhumane, but may lead the trainer to believe that it is doing something to excite the horse.”

Another product called Ozone contained nothing but food grade hydrogen peroxide in water. The “food grade” designation is unsettling to laboratory experts because it means the ingredient has not been created with sufficient purity to be safe for use in medication, let alone an injectable formula.

“Although hydrogen peroxide injections of people have been reported, it is not an approved therapy,” said Sams. “I wondered about the source of the hydrogen peroxide and its strength and purity as well as its stability in the injection vial and whether the peroxide interacted with the vial septum. All of these need to be addressed and answered before the product can be assumed to be safe for administration to horses. Mangini's company did not report conducting any of these studies.”

[Story Continues Below]

A few of the proprietary products may have kicked up a few interesting results on Google had their ingredient lists been made available at the time of purchase, but were probably still bunk.

“As I recall, the Purple Pain was to be administered intravenously, so while there is evidence that ammonium sulfate will interrupt nerve conduction—when injected adjacent to a nerve—there's nothing to suggest that systemic administration would have any effect on pain,” said Scollay. “There is some speculative stuff about L-isoleucine and d-phenylalanine [both found in a formula called Adrenal Cortex] exerting analgesic effects, most of the credible sites said there was no legitimate evidence for that claim.”

Just because it seems like a lot of this stuff didn't work didn't mean it was a harmless waste of money for the trainers who may have been buying it. While it's not uncommon for legitimate pharmacies and pharmaceutical companies to import ingredients from China and elsewhere, there are varying standards to which those products can be held. Shipping receipts seized from Mangini showed that many of the ingredients he purchased were lacking a USP designation after their names. USP stands for United States Pharmacopeia, which is an organization that sets quality, purity, strength, and identity standards for raw ingredients. Imported ingredients with this designation have been verified to meet USP standards.

Several products were listed on shipping receipts as being less than 100% in purity – a no-no for reputable compounders to put in injectable products.

“The 98% pure claims make my skin crawl.  That other 2% can be a killer—literally,” said Scollay.

Not only were many ingredients lacking this seal of approval, Scollay and Sams point out there were a few which contained dyes or colorings to make them appear an appealing color that would match the marketing name given to them. Blast Off Yellow contained yellow food coloring which, of course, isn't intended to be injected into the veins of an animal. It remains unknown what, if any, side effects this could have.

There also isn't a lot of detail provided in the instruction sheets on filtration, which would be a key step in making an injectable formula, though it's possible there were additional instructions on filtration provided in documentation not attached to prosecutors' exhibits. We do know that sanitary conditions in Mangini's facility were lacking – state health inspectors discovered his pharmacy had no working sink for people to wash their hands before compounding drugs and the areas where drugs were made were filthy. They also found that there were no quality assurance tests taking place to check for sterility or endotoxin contamination of products like this one.

Read more about Mangini's pharmacy in this 2016 report.

Then there were the instructions to make ITTP, which is supposed to be expensive to produce, even for much more technically advanced laboratories than Scott Mangini's. Scollay couldn't decide whether the instructions for making that product were more “hilarious or horrifying.”

“Take a bottle of water under the hood, open it,” read the single page of instructions. “Pour 100 ml into one beaker, 100 ml into another. Put 10 g of calcium ball things in one beaker, put 37.5 ittp in the other. Ph the ittp to 7.5. Pour them back into the bottle that has remained under the hood. Shake, it's great. No filter. Yay we are done.”

“I'll say 'c'—all of the above,” said Scollay when considering how she viewed those instructions. “In case there would be any question about the credibility of the laboratory, or how seriously it undertook its tasks—this certainly doesn't read like the business model of a good guy just trying to make good medicine more affordable.  Unless the good guys were the writers at the National Lampoon.”

The heavy hitters

There were substances in the shipping receipts that gave Sams pause. There were some that were intended to be knockoffs of legitimate drugs, and others that were more sinister.

“The products containing dexamethasone, omeprazole, clenbuterol, flunixin, phenylbutazone, and toltrazuril are all generic knockoffs of prescription products,” Sams said. “The FDA requires generic products to be manufactured in FDA-approved facilities according to Good Manufacturing Practices standards. Mangini's operation could not have met these standards. Furthermore, the preparation of knockoff products in bulk as he was doing does not meet the definition of “compounding”.

“The remaining products contain clearly prohibited and performance-enhancing substances such as selective androgen receptor modulating drugs (SARMs) and others. I include injectable clenbuterol in this group because it is not an approved drug in the U.S. Although all of these substances are prohibited in horse racing, they are not DEA controlled substances so no DEA violations occurred.”

Given the manufacturing conditions in Mangini's lab, Sams said veterinarians and trainers could not have relied on the labeled concentrations to be accurate enough to comply with testing thresholds established by state commissions – because those thresholds were created based on the FDA approved versions of the drugs.

The SARMs that attracted the most attention from prosecutors went into a product called Ostarine MK-2866 Oral Solution. Its label promised “Ostarine MK-2866 is in the class of Selective Androgen Receptor Modulators or SARMs. SARMs offer the benefits of traditional anabolic adrogenic steroids such as testosterone, including increased muscle mass, fat loss, and bone density.”

The label also indicated the drug had a 24-hour half life, which would give a user information about how to evade testing.
“Ostarine is extensively metabolized so administration studies had to be performed in order to identify metabolites to facilitate its detection in blood and urine because orally administered ostarine is subject to substantial first-pass effects,” said Sams. “This is a drug of ongoing concern in racing and, in my opinion, is one of the more egregious violations in the Mangini document.”

Other invoices include “Cardanine,” which appears to be a misspelled version of cardarine and Antibolicum LGD4033, which is also a type of SARMs drug. They also reveal the shipment of ITPP, a prohibited substance believed to increase the oxygen-carrying ability of red blood cells. Di-isopropyl diacetate, or pangamic acid, is also among the orders and is also a prohibited substance.

Scollay thought it notable that several products – both knockoffs and proprietary formulas seemed to be reliant on the inclusion of a common thyroid drug.

“Interesting that the Light Explosion and Green Speed contain levothyroxine as their primary ingredient—just in case anyone didn't think it was being used to impact performance,” she said.

L-thyroxine is sold under various trade names, including Thyro-L and Levo-Powder, and was the subject of much concern several years ago, when California regulators discovered that trainer Bob Baffert was giving the substance to all his horses as a feed additive, whether or not they'd been diagnosed with thyroid problems. It remained a topic of concern due to its association with cobalt administration.

Read previous reporting about l-thyroxine here.

Mangini's response

To the extent Mangini responded to some of these issues in court, he maintained that the majority of his sales came from knockoffs of existing drugs like omeprazole (which he was warned by the FDA to stop mass manufacturing). Ostarine, he said, accounted for .5% of his overall sales. Blood Building Explosion, which contained cobalt, was .4% of sales, while Horse Power was .65% of sales.

At sentencing, prosecutors pointed out that the only reference they have to verify Mangini's account of his sales are the records he kept.

“This is not a company that has produced anything remotely like a wholesome breakdown of its finances,” remarked U.S. Attorney Andrew Adams.

Regardless of Mangini's assertion that he didn't actually sell many of the problematic products on offer, Adams pointed out that each bottle of Blood Building Explosion contained many doses, so even the sale of dozens of bottles really resulted in hundreds of doses going into horses pre-race.

For his part, Mangini and his attorney said the former pharmacist was mostly “hurt” by the suggestion that his products were intended to corrupt the industry he loved so much.

“It was wrong to have this internet site and run the pharmacy the way he ran it,” said Mangini's attorney, William Harrington. “He's pled guilty to that. But to suggest that what he's really been doing was to create dozens of products to abuse animals, I just don't support that.”

The post At Long Last, We Know (Kind Of) What Was In Those Products Sold By The Indicted Pharmacist appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights